| Safety and activity of anti-mesothelin antibody-drug conjugate anetumab ravtansine in combination with pegylated-liposomal doxorubicin in platinum-resistant ovarian cancer: multicenter, phase Ib dose escalation and expansion study |
| Santin Alessandro Davide1, Vergote Ignace B.P.2, Gonzalez-Martin Antonio3, Noi Autori4, Bulat Iurie5 |
1 Yale University School of Medicine,
2 University Hospitals Leuven,
3 University of Navarra Clinic, Madrid,
4 Yale School of Public Health, New Haven,
|
| International Journal of Gynecological Cancer |
| Nr. / 2023 / ISSN 1048-891X /ISSNe 1525-1438 |
| Disponibil online 18 April, 2023. Descarcări-7. Vizualizări-249 |
----------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------
1-2 of 2
